Found 17 matching trials
Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
PHASE2RATIONALE: Photopheresis treats the patient's blood with drugs and ultravio...
Location
Mayo Clinic Scottsdale
Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors
NAStem cells collected from sibling donors for allogenic transplants contain ...
Status
Active Not Recruiting
Location
University of Alabama Hospital
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
PHASE1RATIONALE: Rasburicase may be an effective treatment for graft-versus-host ...
Location
Massachusetts General Hospital
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers
PHASE2Background:
Patients with cancers of the blood and immune system often ben...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
SCID Bu/Flu/ATG Study With T Cell Depletion
PHASE1This is a pilot clinical trial of hematopoietic stem cell transplantation f...
Location
Children's Hospital Los Angeles
Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
PHASE1People with severe congenital anemias, such as sickle cell anemia and beta-...
Location
National Institutes of Health Clinical Center
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
PHASE2This study evaluates the efficacy of high-dose post-transplantation cycloph...
Location
First Pavlov State Medical University of St. Petersburg
Stem Cell Transplantation for Patients With Hematologic Malignancies
PHASE3Childhood leukemias which cannot be cured by chemotherapy alone may be effe...
Location
St. Jude Children's Research Hospital
BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
PHASE2The primary objective of this study is to assess the ability of bone marrow...
Location
Johns Hopkins University
Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma
PHASE2RATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells ...
Location
Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University